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IntroductIon
In this chapter, we investigate the evidence perceived to be relevant to 
policy decisions for three contrasting health policy examples in Cambodia – 
tobacco control, HIV/AIDS and performance-based salary incentives. 
These cases allow us to examine the ways that policy relevant evidence may 
differ given the framing of the issue and the broader institutional context 
in which evidence is considered.
It is widely agreed, including within the global health community, that 
data and evidence are essential to inform policy formulation and implemen-
tation (Lavis et al. 2004; Katikireddi et al. 2011; Macdonald and Atkinson 
2011; Franklin and Budenholzer 2009). However the rhetoric of evidence-
based policy – one based on the assumption that research is objective or 
unbiased, and its uptake is a priori positive, with particular emphasis given to 
pieces of evidence classified at the top of so-called ‘hierarchies of evidence’ – 
has long been critiqued by social science scholars (c.f. Oliver et al. 2014a, b; 
Cairney 2015; Cairney et al. 2016; Wesselink et al. 2014; Guyatt et al. 2008; 
Tunis et al. 2003; Liverani et al. 2013; Smith 2013a; Smith and Joyce 2012; 
Smith 2014; Hawkins and Parkhurst 2016). For example, Weiss (1990) has 
argued that research alone ‘is almost never convincing or comprehensive 
enough to be the sole source of political advice’, and ‘there are always issues 
that research doesn’t cover’. Increasingly policy-studies scholars have 
explored aspects of the political system that may shape when, how and the 
types of evidence used within policymaking (Cairney 2015). These can 
include both how political institutions (such as formal structures, and less 
formal rules and norms) (Lowndes and Roberts 2013) and how key ideas 
(including the way that issues are framed and understood) influence which 
types of evidence appear to be relevant for, and are used within, different 
policy processes (Smith 2013a; Shiffman and Smith 2007; Parkhurst 2012).
However, as described by Oliver et al. (2014a), little empirical analysis 
has been undertaken of the processes or impact of evidence use in policy 
and the way that research and policy processes interact. This paper seeks 
to help address this gap, through a comparative examination of the role 
that institutional and ideational factors play in shaping evidence use for 
three contrasting health policy decisions within a single country context. 
Specifically this paper presents findings from research conducted in 
Cambodia, where the Ministry of Health (MOH), like many government 
departments in countries elsewhere (Cabinet Office 1999; Government 
Office for Science 2012; DEFRA 2011), has explicitly embraced the 
overarching language of using ‘evidence-based’ approaches to health 
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policymaking. One example of this endorsement is in the country’s sec-
ond Health Strategic Plan (2008–2015), which defines priorities and 
goals for the entire health sector, highlighting the need “to strengthen 
and invest in health information system and health research for evidence-
based policymaking, planning, monitoring performance and evaluation” 
(Ministry of Health 2008). In this context, our study aimed to examine 
and compare the ways evidence was discussed or used in three contrasting 
health policy areas  – tobacco control, HIV/AIDS and performance-
based financing (PBF)  – in particular for PBF we focus on a widely-
praised government midwifery incentive scheme (GMIS) that was 
introduced to increase deliveries at public health facilities.
Tobacco control represents a policy decision for which there is a long 
history of acknowledged corporate and governmental financial interests 
that have often attempted to influence how health-related evidence is used 
in regulatory policy-making (Bero 2003, 2005; Ong and Glantz 2000; 
Tong and Glantz 2007). HIV/AIDS, on the other hand, is an issue with 
strong donor and global interest, and which has seen policy ideas particu-
larly shaped by global civil society movements and consensus (Parkhurst 
2012; Schneider 2002; Buse et al. 2008; Doyle and Patel 2008). Finally, 
PBF tends to have much less external contestation or debate, but is largely 
seen as a more technical matter related to health economics, health service 
provision or health systems functioning (Mills 2014; Meessen et al. 2011). 
As such, these three examples provide useful ways to reflect on how the 
different institutional settings in which policymaking takes place may 
influence evidence use, including how interests and ideas of key actors 
within the differing institutional arrangements play out in relation to evi-
dence utilisation.
Methods
The paper draws on findings from in-depth semi-structured interviews 
conducted in Cambodia in 2015 and 2016 with stakeholders from key 
health sector organisations, as well as a related documentary analysis. The 
interviews were undertaken as part of a wider research project examining 
political aspects of evidence use for health policymaking in multiple coun-
tries. In case-study countries, key informants were first asked questions 
about the systems and processes through which evidence was used to 
inform health policy broadly, followed by asking for multiple examples of 
recent health policy decisions that could be illustrative of different aspects 
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of evidence use. In all countries we subsequently investigated evidence use 
within tobacco control policy – given the importance of tobacco use for 
health in virtually every country context, as well as the existence of both a 
well-established evidence base and a global policy framework (i.e. the 
World Health Organization’s global framework convention on tobacco 
control). After consultation with local stakeholders, we then selected addi-
tional country-specific health policy decisions of interest or importance to 
enable comparative analysis. As noted earlier, this approach led to the 
selection of three examples in Cambodia: tobacco control, HIV/AIDS 
and performance-based financing.
Key participants were identified though purposive and snowball sam-
pling strategies. In line with our approach, we first approached high-level 
policy makers likely to be knowledgeable about major policy develop-
ments across the entire health sector, and thus could provide a general 
overview of systems and structures in place to use evidence and advice on 
the selection of case studies. Subsequently, a scoping review of relevant 
documents (i.e. published studies and grey literature in the public domain 
such as policy documents and reports) was conducted to collect back-
ground information on each policy issue. This was followed by identifica-
tion of individuals who could comment further on the use of evidence to 
inform the selected policy decision. We endeavoured to conduct inter-
views with people who represented a diverse range of perspectives for the 
health decisions investigated. In total, 26 participants were interviewed, 
including both government representatives as well as individuals repre-
senting influential stakeholders in the policy process, particularly from aid 
providers, non-governmental organisations, multi-lateral organisations, 
and local research institutes.
Interview guidelines focused on the following broad topics, which were 
tailored to the different roles of informants and the specific expertise or 
insights they would bring: (1) perceptions about the policy process, 
including the role of different actors and contextual factors; (2) the nature 
and source of evidence that was used to inform the policy decision; (3) the 
way in which evidence was presented and evaluated; (4) general views on 
institutional structures and practices of evidence use within the Cambodian 
health sector. Interviews were conducted face-to-face by the authors, 
recorded (if permission was given), and subsequently transcribed and 
coded into themes in an iterative process (Bourque 2004). Citations from 
interviews and documents are included in the presentation of results to 
illustrate key points and emerging themes.
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Consent was obtained at the initiation of each interview, with respon-
dents given options on levels of anonymity desired. Ethical approval to 
undertake the study was provided by the London School of Hygiene and 
Tropical Medicine; and research permission obtained from the Cambodia 
National Ethical Committee for Health Research (n. 0120; 06/05/2014).
PolIcy studIes PersPectIves
It is now reasonably well-established that national policy contexts can vary 
considerably with important implications for evidence use. Yet even within 
a single country, the characteristics of evidence use for different health 
issues may also vary considerably. Previous work has made it clear that the 
political nature of policymaking means that there can be multiple compet-
ing interests and concerns at stake for any given policy decision – even 
within the health sector (Parkhurst 2017; Russell et  al. 2008; Cairney 
2015). This indicates that multiple pieces of evidence may be relevant or 
considered in the policy process, depending on the differing concerns at 
stake, rather than any single piece or body of evidence. Thus an important 
step in moving beyond an over-simplistic treatment of evidence use is to 
understand the differing interests of stakeholders holding varying power 
and influence over a given policy decision. Indeed, Cairney notes that 
there can be such contestation at each step of the policy process – from 
defining the problem, to deciding which evidence to generate (or presum-
ably which evidence to consider), to choosing solutions (Cairney 2015).
Scholars have thus begun to apply a range of theories and concepts from 
the policy sciences to help deepen our understanding of evidence use given 
these realities. Pearce (2014), for instance, describes a ‘mistaken consensus’ 
that local climate policy can be based on emissions data, instead drawing 
out how ideas and arguments are also used, and needed to construct local 
policy responses. This view is similar to that of Wellstead et al. (2017), who 
argue that climate change adaptation science advocates are too narrowly 
functionalist in assuming that policies will change in response to feedback 
about climate change. Instead they argue that understanding policy changes 
in this area requires looking not just at the specific problems climate science 
identifies, “but also at the political and institutional factors that transform 
situations into problems and attempt to address them (p. 13)”.
This shift away from thinking about policy problems as fixed, but instead 
to consider how issues become ‘problematised’ directly draws on the field 
of interpretive (or critical) policy studies, which considers the roles of rhet-
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oric or discursive framing in shaping policy outcomes (c.f. Fischer 2003; 
Bacchi 2009; Stone 2002). It is not just climate science, however, which 
has seen such developments in analysis. In looking at health policy, Smith 
(2013a), for example, argues that it is the roles and interplay of ideas (and 
ideas about evidence) that can be critical to understand evidence use within 
differing health-related concerns (Wesselink et al. 2014).
The policy sciences have thus been increasingly applied to questions of 
evidence use in health policymaking and beyond. These perspectives allow 
consideration of the multiple interests and multiple bodies of evidence 
that are important to a policy decision, while further recognising the ways 
that institutional and ideational factors can lead to differing constructions 
of what evidence is seen to be appropriate to address any given interest in 
the first place – with institutional forms and ideas closely linked to the rela-
tive influence of different stakeholders in policy processes.
In this paper, we embrace this approach, applying ideas from new insti-
tutionalism to explore the competing or contrasting constructions of evi-
dence use for a set of three differing health policy concerns in the setting of 
Cambodia. On the one hand, new institutionalism highlights the not just 
the structures in place that shape decision making processes and outcomes, 
but also the importance of rules and norms within organisations that guide 
actor behaviours or decisions (Lowndes and Roberts 2013; Peters 2005). 
The approach also expands the focus of analysis beyond classic comparisons 
of state bureaucracies or legislative forms to consider the nature of institu-
tionalised forces directing policy-relevant action across a much wider set of 
organisational forms, including non-state bodies, collections of stakehold-
ers, or contrasting elements within a government system.
Applying such an approach to the question of evidence use for health 
thus allows us to focus on multiple issues. First we can consider the power 
or influence different stakeholders have over policy processes based on 
their structural positions for a given policy issue – reflecting on how differ-
ent bodies of evidence may be more or less relevant to given stakeholders 
with influence. This approach also, however, allows exploration of the 
institutional logics which those stakeholders possess (c.f. March and Olsen 
1989, 2006) that further shapes uses and understandings of policy- relevant 
evidence. In order to achieve these goals we first provide an overview of 
the three policy areas addressed, followed by a description of the types of 
evidence seen to be applied or important in each case. This is then fol-
lowed by our analytical section that applies this institutional and ideational 
lens to explore such questions.
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one country, three health PolIcy Issues
Tobacco Control
Tobacco smoking became increasingly prevalent in Cambodia in the 
1990s when the country was recovering from its civil war. At this time, 
there emerged the presence of many transnational tobacco companies in 
the country, the most prominent of which was British American Tobacco 
(BAT). The need for foreign investment and lack of regulation of advertis-
ing at this time, was explicitly recognised by British American Tobacco 
(BAT) who described Cambodia as “an attractive and strategically impor-
tant target” (Mackenzie et  al. 2004). A 1993 BAT industry plan, for 
example, acknowledged that awareness of the relationship between smok-
ing and morbidity/mortality would increase in Cambodia through the 
activities of the World Health Organization (WHO), but estimated that 
“the significant revenues generated by tobacco advertising [for the gov-
ernment] will, in the short term, delay anti-smoking initiatives until alter-
native forms of revenue are guaranteed” (Mackenzie et al. 2004). BAT’s 
preferred option was reportedly to become a majority shareholder in a 
joint venture alongside local interests. Such an arrangement would pre-
sumably allow industry control of the composition of company board of 
directors and significant influence over corporation activities, whilst also 
encouraging a local stake in the corporation’s success. BAT achieved this 
in 1995 (Mackenzie et al. 2004).
According to Mackenzie et al. (2004) there was also at this time, owing 
to the lack of regulation, huge scope for tobacco-control advertising and 
promotional activities (Mackenzie et al. 2004). Indeed, a 1994 survey of 
twelve main streets in the country’s capital Phnom Penh recorded 49% of 
the advertising signs (8495  in total) were advertising tobacco products 
(Smith 1996).
HIV/AIDS
HIV/AIDS in Cambodia has a very different history to tobacco smoking. 
In the mid-1990s, Cambodia had one of the fastest growing HIV preva-
lence rates in Southeast Asia, with injecting drug use and commercial sex 
driving HIV transmission (Weiss and de Cock 2001). Adult prevalence 
peaked at approximately 2.0% in 1998 (Pean et al. 2005). Since then, a 
number of prevention and treatment programmes have been introduced, 
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however, and the country’s prevalence has reduced, to an estimated 0.7% 
in 2013 (UNAIDS 2015; Vun et al. 2014).
The response has been divided into three phases: in phase I (1991–2000), 
a nationwide HIV prevention programme targeted brothel-based sex 
work, introduction of voluntary confidential counselling and testing and 
home-based care, and peer support groups of people living with HIV 
emerged; phase II (2001–2011) was characterized by expanding antiret-
roviral treatment (covering more than 80% of the population) and conti-
nuity of care, linking with other health services, accelerated prevention 
among key populations at higher risk (entertainment establishment-based 
sex workers, men who have sex with men (MSM), transgender persons, 
and people who inject drugs), engagement of health workers to deliver 
quality services, and strengthening health service delivery systems; and 
phase 3 (2012–2020) aims to attain zero new infections by 2020 through 
sharpening responses to high-risk population groups, maximizing access 
to community and facility-based testing and retention in prevention and 
care, and accelerating the transition from vertical approaches to linked/
integrated approaches (Vun et al. 2014). In recognition of the country’s 
success in halting and reversing the spread of HIV (relating to the United 
Nations Millennium Development Goal or MDG 6), Cambodia was in 
2010 presented with an MDG Award (UNAIDS 2010).
Performance-Based Financing, and the Case of the Government 
Midwifery Incentive Scheme
The final health issue we explored in relation to the use of evidence was 
that of performance-based financing (PBF), with specific discussion in 
interviews about the role of evidence in supporting the government mid-
wifery incentive scheme (GMIS). In many low and middle-income coun-
tries, PBF is increasingly being used to redress particular aspects of health 
system underperformance, particularly the productivity and quality of 
healthcare providers. It involves offering incentives intended to redress 
underperformance, particularly high worker absenteeism, which is fre-
quently observed in poorly funded public health systems with poor 
accountability (van de Poel et al. 2016). Support for PBF has spread rap-
idly in many countries in recent years (van de Poel et al. 2016). But whilst 
there is considerable enthusiasm for PBF policies, according to a Cochrane 
Collaboration review (2012) of pay-for-performance to improve the deliv-
ery of health interventions in low- and middle-income countries, the 
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current evidence base is too weak to draw any general conclusions regard-
ing effectiveness, with more robust and comprehensive study needed 
(Witter et al. 2012; van de Poel et al. 2016).
According to van de Poel et al. (2016), Cambodia was the first docu-
mented case of a low-income country to experiment with PBF of public 
health care. Since 1999, a variety of health programme funding of districts 
and facilities in Cambodia have been contingent on performance targets 
or have directly linked revenues to services delivered. The main PBF pro-
grammes implemented have specified performance targets relating to child 
vaccination, antenatal care, delivery in a public facility, and birth-spacing 
use. These funding arrangements have been intended to increase aspects 
of healthcare provision, and there has been considerable variation in the 
strength and conditions of the incentives offered (van de Poel et al. 2016).
The interviewees specifically identified the GMIS as a notable PBF pol-
icy, and described how the policy contributed to reducing Cambodia’s 
high maternal mortality ratio (MMR) over recent years. The GMIS 
became operational nationwide in late 2007, following a joint prakas 
(directive) from the MOH and MEF to allocate government budget to 
the incentive payments (Ir and Chheng 2012). The UNFPA was consid-
ered to be behind the policy change, for example through supporting a 
High-Level Midwifery Forum in late 2005 that bought together represen-
tatives from several government departments. However it was the prime 
minister who reportedly ‘gave the green light’ for the policy to go ahead. 
Other stakeholders were not thought to have had much direct influence 
over this decision, and the Cambodian Midwives Council, for example, 
was established after the implementation of the GMIS.
The GMIS aimed to boost facility deliveries by motivating skilled birth 
attendants (or trained health personnel) to promote deliveries in public 
health facilities. It did this by providing midwives (and other trained per-
sonnel) cash incentives based on the number of live births they attended 
in public health facilities – USD15 for a live birth in a health centre and 
USD10 for a live birth in a referral hospital. The reason for the higher 
payment in a health centre than a hospital was to provide a stronger incen-
tive for deliveries at health centres – the recommended facility for normal 
deliveries to be managed (Ir et al. 2015). According to the MOH’s guid-
ance, besides midwives, physicians and other trained health personnel can 
also receive these incentives when attending deliveries in public health 
facilities. Up to 30% of the incentives will be shared with other health per-
sonnel in the facility and eventually with other people such as traditional 
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birth attendants (TBAs) who refer women to the facility for delivery (Ir 
and Chheng 2012). The number of deliveries is reported monthly by 
health facilities through the routine health information system. Based on 
the number of reported deliveries, incentives are disbursed quarterly to 
the facilities through public financial disbursement channels (Ir and 
Chheng 2012).
the nature of evIdence used
In this section we begin to describe and examine the reported differences 
in evidence use between the three policy areas. The evidence relating to 
each issue can be categorised in various ways, including by evidence topic 
(e.g., health, economic) or type (e.g. epidemiological, pilot study), which 
relate to the issue framing by key stakeholders, and the sources relied upon 
(e.g. global literature, national statistics, government survey). What is 
clear, however, is that no single uniform construction of policy relevant 
evidence was seen across cases.
Tobacco Control
Global evidence on tobacco harms were at this time considered well estab-
lished, but local data on smoking rates were fairly limited. In the late 
1990s, Cambodia had some small regional surveys of smoking prevalence, 
but it wasn’t until 2005 that accurate nationwide prevalence data on 
tobacco use were available (Singh et al. 2009). In spite of a lack of local 
data on smoking, in May 2004 Cambodia signed the Framework 
Convention on Tobacco Control (FCTC), a global policy agreement that 
calls for a number of restrictions on tobacco advertising and promotion – 
restrictions which many global health authors present as ‘evidence based’ 
(Myers 2013; Rosen et al. 2013; Glantz and Gonzalez 2012). Many stake-
holders interviewed noted the importance of the FCTC locally, as it 
 dictated that the government could not engage with industry on develop-
ing tobacco control policy. However implementation of the elements of 
the convention were described as only occurring slowly or in limited ways, 
which interviewees suggested was due to industry influence.
For example, one independent health sector consultant explained:
The tobacco industry and lobby is massively powerful here. (IDI1-01, June 2014)
1 IDI, In-depth interview
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Another respondent, a senior civil servant in the MOH, explained:
We don’t know exactly why the law is very slow to be approved. Probably this is 
also due to lobbying of tobacco corporations, but we don’t have evidence to prove 
it. (IDI-10, August 2014)
This individual also noted that tobacco control did not appear to be a 
priority in the national health sector strategic plan.
The context of a deeply entrenched and powerful tobacco interest was 
also manifested in how respondents conceptualised the evidence that was 
relevant for moving tobacco control policies forward. A number of civil 
servants interviewed, for example, stressed the need to counter other evi-
dence the tobacco industry uses to frame tobacco control in a way that 
suits industry interests. For example:
They [tobacco corporations] always complain that if we increase taxes, farmers 
will lose their job. So, you have to explain to the government that, if you increase 
taxes, the margin will not affect the industry. Also, we have to explain that 
farmers do not rely on one crop only, so reduced tobacco production will not 
significantly affect them. (IDI-06, June 2014)
Tobacco industry is powerful and has money. Some people are lobbied by tobacco 
corporations. They [tobacco corporations] have a lot of experience. They can 
approach friends or members of the family and get confidential information 
about policy making. Then, people that are lobbied create opposition at the 
inter-ministerial meetings. They often say that tobacco control will impact on 
the economy and farmers. (IDI-08, August 2014)
Respondents also emphasised the importance of making different 
evidence- based arguments to different actors. In particular, it was noted 
that the Ministry of Economy and Finance (MEF) needed different evi-
dence regarding tobacco control to the MOH to try to convince it to 
support policy action. As one civil servant explained:
You have to find a way to convince people… also because policy is multisectoral. 
It’s not that one minister decides. If you want to increase tax, this is not an issue 
of the Ministry of Health. We don’t have the power to do this. We can do a 
smoke-free policy, but tax is under the Ministry of Finance. So you have to work 
closely with the Ministry of Finance. In Cambodia, when you talk to the 
Ministry of Finance, first you have you prove to them they can make more 
money… The industry can say ‘oh if you increase taxes, you will lose revenue’. 
And you have to present evidence that increasing taxes is not a loss of revenue. 
(IDI-06, June 2014)
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We explain to the government that an increase in tax does not change the over-
all volume of cigarettes that are sold in the market. The case of Thailand shows 
this. Why? Because smoking prevalence decreases, but population increases. 
Cambodia is the same. Smoking prevalence has gone from 49.6% to 42.6%, how-
ever the absolute number of smoking is always 2 million because population 
increased… and you have to tell the government these facts. So you have to do a 
lot of work with the government to prove this. And of course, the tobacco indus-
try makes a lot of money. We cannot stop them. (IDI-06, June 2014)
This civil servant also explained how evidence from neighbouring 
countries was considered influential, as was the normative element of the 
FCTC.
Usually in Cambodia we present evidence or examples from ASEAN2 coun-
tries. How is Vietnam doing? Thailand? Indonesia? Then, we also do interna-
tional. But ASEAN is very important, also because we are approaching the 
ASEAN [Economic] Community in 2015, and member countries do not want 
to be left behind. (IDI-06, June 2014)
Overall, whilst many of the respondents spoke of the slow progress of 
tobacco control policy in Cambodia, the government has made substantial 
progress in tobacco control by banning the advertisement of tobacco 
products in 2011 as well as smoking in workplaces and public spaces in 
2016 using sub-decrees. However it wasn’t until April 2015 that the 
Cambodian National Assembly passed the country’s first-ever law on 
tobacco control, which was ratified later the same month. The new law 
tackles tobacco from a variety of angles, including through import and 
sales restrictions, and bans on sales to minors and pregnant women (FCTC 
Implementation Database 2014).
HIV/AIDS
HIV/AIDS policy-making illustrates a radically different political context 
in which the utilisation of health policy-relevant evidence can be explored. 
The United Nations AIDS programme (UNAIDS) has stated that 
Cambodia has “used high-quality strategic information to inform a [suc-
cessful] evidence-based response” (UNAIDS 2012); and interviews stood 
in dramatic contrast to those with stakeholders advocating for greater 
2 Association of South East Asian Nations.
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tobacco control who expressed the need to develop or discuss evidence of 
financial impact (e.g. on farmers or the treasury) to justify policy action. 
Instead, in discussions of HIV/AIDS, whilst a variety of evidence types 
were clearly brought to bear, NGO and donor-organisation respondents 
discussed how it has often been epidemiological modelling and cost- 
effectiveness analyses (IDI-21, 19, May 2016) – forms of evidence more 
typically advocated by public health actors for priority setting – that were 
seen as important evidence to guide policy. One of the respondents spoke 
about how this approach should be replicated in other areas of health 
policy-making:
I would say for HIV/AIDS it’s that way [evidence use more technical than in 
other areas of policy] every time. I feel like that’s brilliant and the model of 
HIV/AIDS [should] be replicated to other disease, for example we still have a 
very high number of death among pregnant women, the baby, the infant. So 
why don’t they learn from the HIV/AIDS program. (IDI-21, May 2016)
When interviewees were asked about the use of evidence within par-
ticular policy developments, a range of evidence types were described, in 
addition to epidemiological modelling and cost-effectiveness studies men-
tioned above. Other relevant evidence was said to include pilot studies, 
used for example to inform the development of a community-based test-
ing approach implemented in 2013, where the HIV testing is performed 
by lay counsellors – volunteers from population groups at higher risk of 
HIV infection. National prevalence estimates and international evidence 
were also evidence types that were frequently mentioned, particularly with 
international evidence from other Southeast Asian countries, and particu-
larly Thailand. The importance of international evidence may also reflect 
the strong role of donors in HIV/AIDS policy-making in Cambodia.
Yes they [policymakers] welcome [overseas evidence] in the HIV area. I don’t 
know about the other area. They welcome to learn the best practice from the 
region. This week one [NGO] staff member. He joined the field in Bangkok. 
(IDI-20, May 2016)
Epidemiological modelling of future prevalence scenarios has been 
considered key to informing policy as to the prioritization and targeting of 
interventions, preparation of operational plans, budgets and resource 
mobilization efforts (11) (12), and cost-effectiveness analyses such as 
modelling has highlighted areas where technical efficiency might be 
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improved. The National Centre for HIV/AIDS, Dermatology and STI 
(NCHADS) within Cambodia’s MOH, which is responsible for the health 
sector response to HIV and other sexually transmitted diseases, has led the 
analysis, in collaboration with relevant departments and centres of the 
MOH, the National AIDS Authority and other government institutions, 
as well as health service providers, non-governmental and other civil soci-
ety organizations, and development partners.
When asked about the reasons why HIV/AIDS policymaking stood 
out in terms of the use of what is more typically considered policy-relevant 
health evidence, respondents particularly spoke of the strong donor inter-
est and support for HIV policy-making in Cambodia. They felt that this 
was key to driving the type of evidence being used in policy-making, and 
also the relatively well-functioning institutional entry points for such evi-
dence, including here the relevant technical working groups (TWGs) of 
the MOH. One NGO respondent explained:
Yes it’s different [the policy-making process for HIV/AIDS compared to that 
for other health issues]. I think this is because donor support, and I think the 
other thing is because of resource, donor support and resource. Resource, I would 
say financial resource and human capacity resource, let’s say for HIV/AIDS 
they have more educated [staff] and they adhere to plan, they adhere to target 
and they target evidence and I feel like the government take that approach very 
well, participatory approach, it’s very well, because it’s an emergency situation 
but it is also in the situation where funding is allowing so that’s why we feel like 
they are open. (IDI-21, May 2016)
However there were downsides to a donor-driven approach also 
described, including in relation to siloed, non-integrated evidence gather-
ing. When asked what could be improved, one interviewee explained:
Well I think it’s coordination. Because there’s basically the different donor pro-
gramme, donors put all the evidence together. It sits on programmes that are… 
like some donors who are actually doing their own evidence, but not systemati-
cally led by the national programme and disseminated in a timely manner. 
(IDI-19, May 2016)
Interestingly, while HIV/AIDS policymaking has at times been seen as 
controversial or contested in some countries, related to the highly stigma-
tised nature of HIV transmission in some contexts (Rankin et al. 2005; 
Mahajan et al. 2008), we found little evidence of this in Cambodia. Whilst 
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stigma and discrimination towards groups at higher risk of infection (sex 
workers, men who have sex with men (MSM), transgender persons and 
people who inject drugs) were noted, these were perceived to be relatively 
low compared to in many countries elsewhere. Instead, one of the NGO 
respondents explained that in Cambodia policy-makers are relatively 
open – and increasingly so – to discussing these groups and considering 
evidence relating to these groups.
The policy-makers they are more open now… for HIV the policy maker they are more 
open and learn from the [experience of high-risk groups]. (IDI-20, May 2016)
The respondents from a key NGO also spoke at length about the effort 
made by the NGO to engage high-risk population groups in the policy- 
making process, particularly in regard to supporting representatives to 
speak at community meetings and at the MOH TWG meetings.
[The NGO] work to promote that involvement in the policy-making as well, not 
only [the NGO] but also civil society. But we try to involve the key representatives 
from each key population to enrol in the policy-making process… we use the num-
ber, we use the finding, we use the civil society. But also bring the key population to 
talk during the meeting is more powerful… So this is like an MSM person or a sex 
worker, an entertainment worker could stand and speak about their challenges 
and the law enforcement people they listen to this. They’re part of the meeting. 
Everyone is part of the meeting… They also listen and sometimes they [describe] 
their challenges and you can see some improvement. (IDI-20, May 2016)
Performance-Based Financing,  
and the Case of the Government Midwifery Scheme
In contrast to the evidence types seen as relevant for tobacco control and 
HIV/AIDS policy-making, when asked about evidence for policy-making 
in regard to PBF schemes generally, these schemes were described as reli-
ant almost solely on evidence from pilot studies. Interview respondents 
spoke of various pilot schemes of PBF that had been run over the years in 
different districts and by different groups, often by non-governmental 
organisations (NGOs), but also in workplaces of NCHADS.  The per-
ceived dominance of pilots as an evidence type is likely due to specific PBF 
policies being scaled up based on a pilot, but such schemes are likely also 
informed by evidence from health economics more broadly (and indeed, 
from basic microeconomics) that incentives can achieve outcomes (Mankiw 
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and Taylor 2006). When pushed for further examples of evidence use in the 
PBF area, some respondents mentioned evidence from the Demographic 
and Health Survey, and also international evidence as informing the use of 
such schemes – but respondents didn’t provide specific examples of such 
evidence. Some mentioned the low payment of midwives and the lack of 
incentives for women to deliver in health facilities as evidence for needed 
change.
I don’t think anyone guided the government to design that policy. But it came 
clearly from many dialogues that the pay was not enough, that the arrange-
ments did not encourage midwives to work in remote health centres, and did 
not encourage mothers to use health facilities. (IDI-11, June 2014)
A few years ago there was a policy to put one midwife in each health centre and 
the midwifery incentive… Hun Sen acted on this, and the policy was imple-
mented immediately and very effectively… the. trigger was the Demographic 
and Health Survey… it has quite a bit of impact, and there was a lot of pressure 
from the international community… it was a relatively ‘easy fix’, a simple solu-
tion. (IDI-12, June 2014)
However, the dominance of pilots as an evidence type fits with observa-
tions from van de Poel et al. (2016) above, of Cambodia’s pioneering role 
in experimenting with PBF of public health care, and also with one of our 
respondent’s description of Cambodia as ‘a country of pilots’ (IDI-23, 
May 2016).
In contrast, however, there was also considerable discussion of that at 
times policy directives come from high levels of government – within the 
MOH, or as a decision made by the Prime Minister himself – and that in 
such situations evidence is perceived to be of limited importance. The 
GMIS was described as an example of this at times:
That [the GMIS] was an example of policy being changed by the government. 
It’s the government’s job, without any evidence. (IDI-15, May 2016)
You know, in the United States the evidence has, as far as can tell, no effect on 
congress. But what happens is they pass laws and then health and human ser-
vices when they’re putting out the regulations or something, that’s where the 
evidence comes in. Here it’s more like everything at the congress level, even there 
is no, it doesn’t get more rational as it comes down through the MOH… People 
have very set ideas about things and those aren’t going to change no matter 
what evidence is put in front of them. (IDI-22, May 2016)
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You can present the evidence and present it passionately and you can present it 
unanimously when you are heard, but there’s never really a proper policy dia-
logue. So saying well I could go and speak to the Ministry of Economy and 
Finance about that, we need extra money or we need to look at the budgets or 
perhaps we need to revise the [pre-service] training curriculum. You don’t get 
that. (IDI-15, May 2016)
We don’t even know who made it. There’s a re-writing of history that claims the 
MOH thought about it but there was no evidence. I was here right after it 
started and know many people here when it started. At the time no-one was 
claiming the MOH invented it, so it came out of the MEF, the Ministry of 
Economy and Finance. It was actually hugely successful. (IDI-22, May 2016)
Another respondent from a donor agency was unable to name evidence 
in support of the policy, and instead described how he saw the policy pro-
cess for the GMIS.
I think in Cambodia evidence [is not so important, rather] government want 
the community to deliver their baby at the health facility so the government 
just simply providing incentive to the health staff, community wide, so for 
delivery of one live birth delivery, they get $15.00 this is the decision by the 
government and government budget and then see if they implemented that. 
(IDI-17, May 2016)
This perception of success appears to come from data showing increas-
ing facility utilisation for delivery and falling mortality rates nationally 
after implementation of the programme. Since then, the percentage of 
deliveries in public health facilities has increased substantially, from 29% 
in 2006 to 57% in 2011, and the MMR has declined substantially from 
473 per 100,000 live births in 2005 to 206  in 2010 (Ir and Chheng 
2012). Care, of course, is needed with interpretation of such evidence. A 
number of evaluations of PBF schemes such as the GMIS have been 
undertaken, and PBF policies have been credited with developments 
including increasing utilisation by the poor, decreasing total family per 
capita health expenditure and encouraging better management (Eldridge 
and Palmer 2009)  – but drawing firm conclusions of causality can be 
problematic, particularly when such programmes have been implemented 
alongside other health sector reforms (Soeters and Griffiths 2003). One 
respondent further commented that the quality of evaluations undertaken 
is often poor.
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InstItutIonal features and logIcs of evIdence use
The three policy areas presented show few similarities in how pieces of 
evidence were used in various aspects of policy making, despite all being 
discussed or undertaken within a single MOH, and within a broad policy 
environment in which ‘evidence based policymaking’ is rhetorically cham-
pioned. In this section, however, we draw out some of the particular insti-
tutional and ideational features of the three health policy concerns that 
may help to explain these findings.
A starting point is to compare the institutionalised positions of influ-
ence of the key stakeholders in each case, to reflect on how the relevance 
of particular evidence types fit with the interests of such stakeholders. This 
can then be followed by considering any contrasting institutional logics 
that similarly might help explain differences in evidence utilisation. Such 
logics could either be direct thinking about which evidence is relevant and 
why (such as how public health actors explicitly embrace hierarchies of 
evidence at times), or they may be related to the overarching goals or 
expectations of the actors involved, which subsequently shapes their uses 
of evidence (such as when particular types of evidence more naturally align 
with or fit broader goals).
In the case of tobacco control, the historical influence of the tobacco 
industry appears particularly relevant, and the nature of contestation for 
this issue appeared to principally be framed in terms of financial implica-
tions of tobacco control. Our respondents described the financial impor-
tance of tobacco for the agricultural sector and the national economy as the 
paramount concerns for any policy change. Tobacco control were well 
aware of the need to present different evidence and frame the issue differ-
ently to address the concerns of the most influential stakeholders – with a 
particular distinction made between the health and economic evidence 
needed when speaking to policy-makers from the MOH and MEF, respec-
tively. The need for taxation and other regulatory policy to be made out-
side the MoH illustrated how limited health-related evidence of tobacco 
harms could be in driving tobacco control policy forward on its own.
Evidence from neighbouring countries, and the FCTC, were said to be 
influential. But even so, and despite considerable progress, policy change 
in line with these was described as particularly slow, as too was the devel-
opment of what were considered more appropriate forms of evidence to 
guide tobacco policy from a public health perspective, such as national 
smoking prevalence surveys. Despite global evidence on tobacco harms 
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and increasing local data on smoking, it was the concerns regarding eco-
nomic growth and the industry’s entrenched interests and lobbying docu-
mented in our study and elsewhere (Mackenzie et al. 2004; Collin et al. 
2004; Mackay 2004) that dominated the agenda. As such this significantly 
appeared to slow down the translation of the FCTC into local tobacco 
control policies; as well as the collection of, or action based on, forms of 
evidence typically seen as relevant to health promotion.
In contrast, the HIV/AIDS policy response in Cambodia developed in 
a rather different political context. With HIV/AIDS, there was no estab-
lishment of corporate interests, and little obvious financial interest at stake 
for any major stakeholders. Instead, the issue may have achieved a rela-
tively high level of priority for policy action in Cambodia due to the atten-
tion and resources this issue has been accorded by donor agencies, and 
possibly related to this, the well-functioning TWGs of the MOH for HIV 
policy-making, as described by our respondents. The institutionalisation 
of donor influence is, in fact, reflected within the country’s various strate-
gic documents for guiding programme implementation – including the 
National Strategic Plan for HIV/AIDS, 2011–2015 (NSP III) and 
Cambodia 3.0, a strategy developed by the country’s Ministry of Health 
to eliminate new HIV infections and congenital syphilis by 2020. Both are 
considered to be in line with the global targets and foci established by 
UNAIDS and the US PEPFAR programme (from which Cambodia is a 
recipient of funds) (PEPFAR 2015; UNAIDS 2015). These are highly 
technical global policy agencies, however, who routinely promote, or 
operate based around, particular forms of evidence types  – embracing 
international discourses of evidence-based policy making. This may trans-
late to the Cambodian context, particularly if there were no other strong 
interest groups to present alternative rhetoric or framing around the 
issue – and as such may have led to the use of evidence types in Cambodia 
more typically advocated by public health advocates in HIV/AIDS policy- 
making, and the observation of one NGO respondent that the National 
HIV/AIDS Centre is ‘big on evidence’ (IDI-25, May 2016).
Indeed, while in many countries the issue of HIV testing has been sub-
ject to debate or controversy – particularly around issues of disclosure or 
confidentiality of people living with HIV, and the challenges associated 
with addressing HIV in oft-stigmatised groups such as men who have sex 
with men, transgender people and sex workers – these concerns were con-
sidered by our respondents to have been relatively unimportant in 
Cambodia (even if admittedly seen as sensitive). That HIV/AIDS is an 
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issue with social connotations in Cambodia perhaps explains the use of 
narrative evidence  – stories of the lived experiences of marginalised 
groups – to influence policy-making. However, the relatively low level of 
moral contestation for this issue in Cambodia was noted – and used to 
explain the recent introduction of community-based rapid HIV testing 
(so-called ‘finger-prick testing’) by lay volunteer counsellors for high-risk 
population groups. Within this recent national policy, however, it was 
again evidence of effectiveness provided from a pilot study that could be 
seen to lead to policy change (KHANA 2014; Ministry of Health 2012).
The importance of pilots, however, was much more apparent, and 
described as the primary source of policy-relevant evidence for PBF. This 
was in contrast to tobacco policy appearing to require discussion of evi-
dence of financial impact (linked to the influence of one set of interest 
groups), and HIV policy drawing particularly on epidemiological models 
and surveys (in line with norms and expectations of global health agen-
cies). Again, however, we can look to the most influential stakeholders 
involved and their institutional logics to help explain the emphasis on 
pilots as a form of evidence in this case. Indeed, this helps to move away 
from the oft-criticised over-reliance on the idea that a single hierarchy of 
evidence can guide policy decisions, to instead consider the policy ‘appro-
priateness’ of particular forms of evidence (Parkhurst and Abeysinghe 
2014; Dobrow et al. 2004; Young et al. 2002).
Unlike the previous cases, the GMIS policy appears to have had few 
stakeholders outside the government itself. It was reportedly made from 
the highest levels of the government, with some interviewees speculating 
that it was driven by the Prime Minister’s office in particular in response to 
a feeling that some action must be taken to help achieve the maternal health 
millennium development goal by 2015. The power and influence in this 
case appeared to be particularly hierarchical, with decision making made 
through a planning and management orientation. Pilot studies, which 
examine feasibility of an intervention, are a first step in exploring novel 
interventions, novel applications of an intervention, or the feasibility of an 
intervention in a particular context when the effectiveness of that interven-
tion may be context dependent (Leon et al. 2011). For this reason, they are 
often considered important evidence of effectiveness as well as feasibility 
within a particular context and for complex interventions, on the premise 
that cultural appropriateness of interventions is important and can shape 
outcomes (Bernal et al. 2009). As such, pilot studies have been described 
previously as particularly applicable in health services and health systems 
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research (Craig et al. 2013), but they also could be seen to be particularly 
relevant when a government has decided that wide-scale implementation of 
an intervention is a primarily objective at hand, such as achieving an MDG 
target through reducing the high maternal mortality rate.
In Table 2.1, we present a summary of these findings. In particular we 
highlight the stakeholders established to have dominant influence in each 
policy case, and their institutional interests and logics that help to explain 
the evidence said to be used by our interviewees.
dIscussIon
Despite a common use of the language of evidence-based policy making in 
the health sector, there are in fact many types of evidence which can speak 
to a variety of political concerns and mandates that play out in the policy 
process. Sometimes evidence use differs because the evidence needs differ 
Table 2.1 Characterisation of the institutional and ideational factors related to 
the health policy issue
Health 
policy 
area
Established 
dominant 
stakeholders
Institutional 
interests and logics
Nature of evidence used
Types Topic Source
Tobacco 
control
Industry, 
MEF
Financial 
importance of 
tobacco for 
agriculture sector 
and national 
economy
Regional 
surveys
Health Local 
government,
Epidemiological Health Global 
repositories
Economic Finance Local sources
HIV/
AIDS
International 
donors
Hierarchy of 
evaluation 
evidence; 
importance of 
achieving global 
targets
Epidemiological Health Global, local 
sources
Economic Finance Local sources
Pilot studies Health Local sources
Narrative Social Citizens
PBF – 
GMIS
MoH, MEF, 
Prime 
Minister
Importance of 
achieving global 
targets; importance 
of achieving 
national 
implementation
Pilot studies Health Local 
(government, 
NGO)
Epidemiological Health Local sources
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to solve an agreed upon problem. At other times, there may not be any 
agreement on the nature of the problem, however, and as such it is fea-
tures of power, interests, and framing that serve as important drivers shap-
ing which evidence informs policy considerations. An institutionalist 
approach, however, can help to understand some of these dynamics. It can 
identify which stakeholders have established positions of power within dif-
fering health policy issues, linking their interests to the nature of evidence 
used. It can also reflect on the institutional logics of these stakeholders 
which further may influence when or how evidence is utilised.
For tobacco, large and expensive national prevalence surveys were con-
sidered necessary evidence for intervention, even given considerable evi-
dence from smaller studies of a high prevalence of smoking in the country, 
and the irrefutable global evidence linking tobacco to numerous diseases 
and mortality. Such surveys, however, were needed because of a demand 
for evidence that could speak to the dominant concerns of financial impact 
and the logic that evidence was needed to illustrate economic impact, 
rather than any public health logic of evidence to show medical harm to 
the population. The importance of the ministry of finance is thus apparent 
in this case – illustrating both its dominant policy concern in terms of the 
economy, but also its logic of what forms of evidence are required to speak 
to that concern. Furthermore, it is of course critical to understand the 
historical influence and role of the tobacco industry in the country, which 
no doubt has played an important role in shifting the terms of tobacco 
policy to one of revenue.
In contrast, for the case of HIV/AIDS, the dominance of global donors 
in supporting this health issue, and the apparent limited contestation at a 
local level, appears to have led to the explicit embrace of epidemiological 
evidence that is widely held to be appropriate for HIV planning within the 
global health community. In the final case of PBF, however, it was the 
government that drove both the initiation and implementation of the pol-
icy response. This state-controlled process appeared to reflect a belief that 
national action must be taken to address an existing priority (in the form 
of a Millennium Development Goal). This in turn naturally led to a logic 
which saw relatively micro studies focussed on implementation to be the 
most policy-relevant. Although it is worth noting that in the case of the 
GMIS, some believed that evidence was not perceived as important at all, 
due to the policy being driven by higher level political authorities. Indeed, 
some stakeholders simply referred to the GMIS policy when asked for 
good example of the use of evidence because it was national action based 
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around the ‘evidence’ that maternal mortality rates were too high – a much 
simpler logic of evidence informed policymaking whereby evidence of a 
problem is seen to justify widespread action, in contrast to more traditional 
health sector descriptions of evidence use being concerned with the effec-
tiveness of interventions or possible alternative priorities or approaches.
Policy studies scholars would not be surprised, however, that powerful 
stakeholders (or ‘vested interests’) end up shaping the understanding of 
evidence, or which pieces of evidence are championed as relevant for 
 policy making. This is perhaps most clearly illustrated in how evidence has 
been presented or selected by the tobacco industry in relation to policy-
making debates (c.f. Smith 2013b; Ulucanlar et al. 2014; Tong and Glantz 
2007; Bero 2005). For example, tobacco industry-funded studies have 
been shown to have misrepresented the association between second-hand 
smoke and CVD (Tong and Glantz 2007), or the evidence in support of 
standardised packaging of tobacco products (Ulucanlar et  al. 2014). 
Tobacco interests have also emphasised evidence in support of the eco-
nomic contributions of their product, whilst questioning the evidence 
suggesting that policy interventions are needed to protect health (Smith 
2013b). HIV/AIDS, on the other hand, touches on issues of gender and 
sexuality, drug use and sex work, which often leads to it being seen as a 
highly morally-contested issue. However these did not appear particularly 
relevant in Cambodia, serving as a reminder that we cannot assume a 
health topic will necessarily exhibit the same political characteristics in dif-
ferent settings, even if such features are commonplace in other cases.
conclusIons
In the three contrasting case studies of evidence use in health policy- 
making examined in this study, evidence types – and their framing – were 
found to differ greatly, despite them taking place in the same country set-
ting. The findings reiterate past authors’ understandings that ‘evidence’ is 
not a uniform concept for which more is obviously better, or where a 
single model of ‘evidence based policymaking’ can prevail, but rather that 
different constructions and pieces of evidence become relevant given the 
politics involved in policy decisions, the nature of institutions involved, 
and the framing and conceptualisations of the issues themselves. Our com-
parative analysis helps to begin to trace out themes in linkages between the 
nature of contestation of health issues, the interests of established domi-
nant stakeholders, and the logics by which those stakeholders operate – all 
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of which work to shape which evidence is utilised or seen as policy relevant 
to inform health decisions. Whilst considerable further empirical research 
is needed in this area, this more nuanced understanding of evidence use 
may be of relevance to health policy-makers and others considering how 
to improve the role of evidence in health policy making.
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